Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2
US-12595289-B2 · Apr 7, 2026 · US
Oncotherapy Science Inc holds 118 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 118 |
| Recent patents | 4 |
| First publication | Jan 13, 2015 |
| Latest publication | Apr 7, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12595289-B2 · Apr 7, 2026 · US
US-12195559-B2 · Jan 14, 2025 · US
US-2023357328-A1 · Nov 9, 2023 · US
US-11673915-B2 · Jun 13, 2023 · US
US-2023159588-A1 · May 25, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12595289-B2 · Apr 7, 2026 · US
US-12195559-B2 · Jan 14, 2025 · US
US-2023357328-A1 · Nov 9, 2023 · US
US-11673915-B2 · Jun 13, 2023 · US
US-2023159588-A1 · May 25, 2023 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 110 |
| A61K38/00 | 86 |
| A61K39/0011 | 79 |
| C07K7/06 | 77 |
| A61P37/04 | 64 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 116 |
| Chemistry & Metallurgy | 116 |
| Physics | 59 |
| Cross-Sectional Technologies | 7 |
| Operations & Transport | 2 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.